Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 94.39 M95.93 M90.27 M99.45 M 380.04 M Research & development ———— — Operating income 32.33 M52.05 M53.36 M35.36 M 173.1 M Non-Operating Income, Total -774 K-3.41 M-659 K-1.82 M -6.67 M Interest expense, net of interest capitalized 2.67 M4.44 M4.21 M6.48 M 17.8 M Non-Operating Income, excl. Interest Expenses -2.67 M-4.44 M-4.21 M-6.48 M -17.8 M Unusual income/expense -774 K-3.41 M-659 K-1.82 M -6.67 M Pretax income 28.89 M44.19 M48.49 M27.06 M 148.63 M Equity in earnings ———— — Taxes 5.28 M11.63 M2.34 M2.67 M 21.93 M Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations 23.61 M32.56 M46.15 M24.39 M 126.71 M Discontinued operations ———— — Net income 23.61 M32.56 M46.15 M24.39 M 126.71 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 23.61 M32.56 M46.15 M24.39 M 126.71 M Basic earnings per share (Basic EPS) 0.410.560.790.42 2.18 Diluted earnings per share (Diluted EPS) 0.40.550.780.41 2.14 Average basic shares outstanding 58.1 M58.55 M58.37 M58.38 M — Diluted shares outstanding 59.01 M59.07 M59.13 M59.16 M — EBITDA 41.19 M59.66 M61.95 M41.16 M 203.95 M EBIT 31.31 M49.83 M52.01 M31.41 M 164.56 M Cost of revenue 204.31 M227.54 M220.89 M214.59 M 867.34 M Other cost of goods sold ———— — Depreciation & amortization (cash flow) 9.88 M9.83 M9.94 M9.75 M 39.39 M